Literature DB >> 10447757

Tissue distribution of the rat analogue of decay-accelerating factor.

O B Spiller1, S M Hanna, B P Morgan.   

Abstract

In humans, decay-accelerating factor (DAF) is a widely distributed, cell-bound inhibitor of the complement activation enzymes and plays a key role in regulating complement activation, preventing the generation of anaphylotoxins and opsonins, and protecting against complement-mediated lysis. Rodent analogues of DAF have recently been identified, providing a new avenue for the analysis of function. Rat DAF was cloned in our laboratory. Here we describe the generation of monoclonal antibodies (mAbs) against rat DAF, using transfected cells as immunogen, and their use in the analysis of the distribution of DAF in the rat by flow cytometry, Western blot analysis and immunohistochemistry. One of the mAbs was found to block the complement inhibitory function of rat DAF, offering the prospect of neutralization of DAF function in vivo. The antibodies have also been used for purification of DAF from rat erythrocytes by affinity chromatography. Rat DAF purified in this manner was similar in molecular mass to human DAF. The purified protein incorporated into lipid membranes, confirming the presence of a glycolipid anchor, and incorporated protein strongly inhibited the rat C3 convertase. Rat DAF was strongly expressed on endothelia throughout the animal and was also present in most tissues and organs. DAF expression was weak or absent in the brain and on circulating and spleen-resident T cells. Strong DAF expression observed in the kidney was restricted to the glomerulus and Bowman's capsule. DAF expression in the testis was found only in association with the later stages of spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447757      PMCID: PMC2326868          DOI: 10.1046/j.1365-2567.1999.00776.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.

Authors:  L W Terstappen; M Nguyen; H M Lazarus; M E Medof
Journal:  J Leukoc Biol       Date:  1992-12       Impact factor: 4.962

2.  Natural killer cells are deficient in the surface expression of the complement regulatory protein, decay accelerating factor (DAF).

Authors:  A Nicholson-Weller; D A Russian; K F Austen
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

3.  Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.

Authors:  M H Holguin; L R Fredrick; N J Bernshaw; L A Wilcox; C J Parker
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

Authors:  A Nicholson-Weller; J Burge; D T Fearon; P F Weller; K F Austen
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Preparation of monoclonal antibodies: strategies and procedures.

Authors:  G Galfrè; C Milstein
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.

Authors:  A Nicholson-Weller; J P March; S I Rosenfeld; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

7.  Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins.

Authors:  I W Caras; M A Davitz; L Rhee; G Weddell; D W Martin; V Nussenzweig
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

8.  Localization of the complement regulatory proteins in the normal human kidney.

Authors:  S Ichida; Y Yuzawa; H Okada; K Yoshioka; S Matsuo
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

9.  In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats.

Authors:  S Matsuo; S Ichida; H Takizawa; N Okada; L Baranyi; A Iguchi; B P Morgan; H Okada
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

10.  Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins.

Authors:  D M Lublin; M K Liszewski; T W Post; M A Arce; M M Le Beau; M B Rebentisch; L S Lemons; T Seya; J P Atkinson
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  10 in total

1.  Interaction between host complement and mosquito-midgut-stage Plasmodium berghei.

Authors:  G Margos; S Navarette; G Butcher; A Davies; C Willers; R E Sinden; P J Lachmann
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies.

Authors:  F Lin; Y Fukuoka; A Spicer; R Ohta; N Okada; C L Harris; S N Emancipator; M E Medof
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

3.  Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.

Authors:  Claire L Harris; S Melanie Hanna; Masashi Mizuno; Dewi S Holt; Kevin J Marchbank; B Paul Morgan
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

4.  GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins.

Authors:  K D Whitney; J O McNamara
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

5.  Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46).

Authors:  R Mead; S J Hinchliffe; B P Morgan
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

6.  Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli.

Authors:  Jennifer White; Petra Lukacik; Dirk Esser; Michael Steward; Naomi Giddings; Jeremy R Bright; Sarah J Fritchley; B Paul Morgan; Susan M Lea; Geoffrey P Smith; Richard A G Smith
Journal:  Protein Sci       Date:  2004-09       Impact factor: 6.725

7.  A protein toxin from the sea anemone Phyllodiscus semoni targets the kidney and causes a severe renal injury with predominant glomerular endothelial damage.

Authors:  Masashi Mizuno; Masatoshi Nozaki; Nobuya Morine; Norihiko Suzuki; Kazuhiro Nishikawa; B Paul Morgan; Seiichi Matsuo
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

8.  Structures of the rat complement regulator CrrY.

Authors:  Pietro Roversi; Steven Johnson; Joseph J E Caesar; Florence McLean; Kirstin J Leath; Stefanos A Tsiftsoglou; B Paul Morgan; Claire L Harris; Robert B Sim; Susan M Lea
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-06-23

9.  Expression of Membrane Complement Regulatory Proteins Crry and CD55 in Normal Rats.

Authors:  Chie Kato; Atsuhiko Kato; Kenji Adachi; Etsuko Fujii; Kaori Isobe; Takeshi Watanabe; Tsuneo Ito; Masami Suzuki
Journal:  J Toxicol Pathol       Date:  2013-07-10       Impact factor: 1.628

10.  Anti-Thy-1 Antibody-mediated Complement-dependent Cytotoxicity is Regulated by the Distribution of Antigen, Antibody and Membrane Complement Regulatory Proteins in Rats.

Authors:  Chie Kato; Atsuhiko Kato; Kenji Adachi; Etsuko Fujii; Kaori Isobe; Tomochika Matsushita; Takeshi Watanabe; Masami Suzuki
Journal:  J Toxicol Pathol       Date:  2013-04-22       Impact factor: 1.628

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.